Comparison of albumin-(Gd-DTPA)30 and Gd-DTPA-24-cascade-polymer for measurements of normal and abnormal microvascular permeability

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 2, 1997, Pages 331-338

  Roberts, Heidi C ^a,b   Saeed, Maythem ^a   Roberts, Timothy P L ^a,b   Mühler, Andreas ^c   Shames, David M ^a   Mann, Jeffrey S ^a   Stiskal, Michael ^a   Demsar, Franci ^a   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Macromolecular contrast agent; Magnetic resonance imaging; Microvascular permeability

Indexed keywords

ALBUMIN; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CELL MEMBRANE PERMEABILITY; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DATA ANALYSIS; ENDOTHELIUM CELL; EXTRACELLULAR SPACE; EXTRAVASATION; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CONTRAST MEDIA; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FEMALE; GADOLINIUM DTPA; HEART NEOPLASMS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIAL REPERFUSION INJURY; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0031397414     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070213     Document Type: Article

References (49)

1. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994; 29:94-104.
2. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22:282-287.
3. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-braln-barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990; 16:117-131.
4. Schwickert HC, Roberts TPL, Mühler A, Stiskal M, Demsar F, Brasch RC. Angiographic properties of Gd-DTPA-24-cascadepolymer: a new macromolecular contrast agent. Eur J Radiol 1995; 20:144-150.
5. Schwickert HC, Stiskal M, Roberts TPL, van Dijke CF, Mann J, Mühler A, Shames DM, Brasch RC. Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of preirradiation on the tumor delivery of chemotherapy. Radiology 1996; 198:893-898.
6. Cohen FM, Kuwatsuru R Shames DM, Neuder M, Mann JS, Vexler V, Rosenau W, Brasch RC. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest Radiol 1994; 29:970-977.
7. Weinmann H-J, Brasch RC, Press W-R, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 1984; 142:619-624.
8. Alcher KP, Dupon JW, White DL, Aukerman SL, Moseley ME, Juster R, Rosenau W, Winkelhake JL, Brasch RC. Contrastenhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor γ. Cancer Res 1990; 50:7376-7381.
9. Denekamp J. Vascular endothelium as the vulnerable element in tumours. Acta Radiol (Oncol) 1984; 23:217-225.
10. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133:95-109.
11. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31;288-305.
12. Gusterson BA, Warburton MJ, Mitchell D, Eilison M, Neville AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins In the normal breast and In benign and malignant breast diseases. Cancer Res 1982; 42:4763-4770.
13. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987; 6:559-569.
14. Parish CR. KB Jakobsen, DR Coombe. A basement-membrane permeability assay which correlates with the metastatic potential of tumor cells. Int J Cancer 1992; 52:378-383.
15. Peterson H-I, Appelgren KL, Lundborg G, Rosengren BHO. Capillary permeability of two transplantable rat tumors as compared with various normal organs of the rat. In: Proceedings of the 7th European Conference on Microcirculation, Part II. Aberdeen: 1972; 12:511-518.
16. Peterson H-I, Appelgren KL, Rosengren BHO. Experimental studies on the mechanisms of fibrinogen uptake In a rat tumour. Eur J Cancer 1972; 8:677-681.
17. Wikström MG, Moseley ME. White DL, et al. Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989; 24:609-615.
18. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation In invaslve breast carcinoma. N Engl J Med 1991; 324:1-8.
19. Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeabiltty of tumor blood vessels. Lab Invest 1992; 67:596-607.
20. Baxter AB, Menikoff S, Stites DP, Brasch RC. Immunogenicity of gadolinium-based contrast agents for magnetic resonance imaging. Invest Radiol 1991; 16:1035-1040.
21. 15-20: whole-body clearance, plasma clearance and organ distribution of gadolinium (abstract). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1989. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1989; 807.
22. Shames D, Kuwatsuru R, Vexler V, Mühler A. Brasch RC. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 1993; 29:616-622.
23. Kuwatsuru R, Shames DM, Mühler A, et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993; 30:76-81.
24. Brasch RC. Macromolecular contrast media for magnetic resonance imaging. In: Katayama H, RC Brasch, eds. New dimensions of contrast media. Proceedings of the Second International Symposium on Contrast Media. Osaka, Japan, 1990. Amsterdam: Excerpta Medica, 1991; 349-355.
25. Bogdanov A, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993; 187:701-706.
26. Adam G, Neuerburg J, Spüntrup E, Mühler A, Scherer K, Günther RW. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging. JMRI 1994; 4:462-466.
27. Adam G, Neuerburg J, Spüntrup E, Mühler A, Scherer K, Günther RW. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magn Reson Med 1994; 32:622-628.
28. Hilf R, Freeman JJ, Michel I, Borman A. Characterization of a transplantable cactating mammary tumor: endocrinological, morphological, and biochemical aspects. Cancer Res 1964; 24: 812-823.
29. Bogden AE. Therapy in experimental breast cancer models. In: McGuire WL, ed. Breast cancer 2. Advances in research and treatment. Experimental biology. New York: Plenum Medical Book Company, 1989; 283-336.
30. Less JR. TC Skalak, EM Sevick, RK Jain. Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991; 51:265-273.
31. Wolfe CL, Moseley ME, Wikstrom MG, et al. Assessment of myocardial salvage after ischemia and reperfuslon using magnetic resonance imaging and spectroscopy. Circulation 1989; 80;969-982.
32. Sievers RE, Schmiedl U, Wolfe CL, et al. A model of acute regional myocardial ischemia and reperfusion in the rat. Magn Reson Med 1989; 10:172-181.
33. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987; 22;665-671.
34. Schmiedl U, Ogan M, Moseley ME, Brasch RC. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR 1986; 147:1263-1270.
35. Schmiedl U, Ogan M, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-210.
36. Roberts TPL. Physiologic measurements by contrast enhanced MRI: expectations and limitations. JMRI 1997; 7:82-90.
37. Schwickert HC, Roberts TPL, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient-recalled echo imaging. Magn Reson Med 1995; 34:845-852.
38. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
39. Patlak CS, Goldstein DA, Hoffman JF. The flow of solute and solvent across a two-membrane system. J Theor Biol 1963; 5: 426-442.
40. Brasch RC, Shames DM, Cohen FM, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 1994; 29:S1-S4.
41. Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271:58-65.
42. Wilke N, Jerosch-Herold M, Mühler A, et al. 24-Gd-DTPA-cascade-polymer - a novel Intravascular relaxation contrast agent for cardiac MR first pass imaging (abstract). In: Book of abstracts: Society of Magnetic Resonance in Medicine. Berkeley, Ca: Society of Magnetic Resonance in Medicine, 1994; 112.
43. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volumes by rapid T1 mapping. Magn Reson Med 1993; 29:709-712.
44. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621-628.
45. Su M-Y, Jao J-C, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994; 32: 714-724.
46. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
47. Eskey CJ, Koretsky AP. Domach MM, Jain RK. 2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 1992; 52:6010-6019.
48. Schleifer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994; 89:2273-2282.
49. Oksendal AN, Hals P-A. Biodistribution and toxicity of MR imaging contrast media. JMRI 1993; 3:157-165.